Trusted Press Release Distribution   Plans | Login    

Briefing Search


Author Details
Venkat Reddy
(+1) 614-588-8538

Bookmark and Share
Asthma and COPD Devices Market Size to Grow at a CAGR of 4.3% During the Forecast Period 2020-2025
"Increasing Prevalence of Respiratory Disorders Such as Asthma and COPD Are the Major Factors Driving the Growth of the Asthma and COPD Devices Market. ", 4/12/2021 - Asthma and COPD Devices Market size in 2019 is estimated to be $35 billion, growing at a CAGR of 4.3% during the forecast period 2020-2025. Asthma and COPD (chronic obstructive pulmonary disease) are types of chronic inflammatory lung disorder that cause breathing problems and narrows the airways. Asthma and COPD have similar symptoms such as chronic coughing, wheezing, and shortness of breath. To treat these disorders inhalers and nebulizers are commonly used devices to get medicine into your lungs. Increasing prevalence of respiratory disorders such as asthma and COPD are the major factors driving the growth of the market. Moreover, a growing development of advanced portable inhalation devices further enhance the overall market demand for Asthma and COPD Devices during the forecast period 2020-2025.

Key Takeaways

In 2019, North America dominates the Asthma And COPD Devices Market owing to increasing prevalence of asthma and COPD diseases in this region.

Increasing government initiatives and rising awareness about asthma and COPD devices are driving the market growth of Asthma And COPD Devices.

Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Asthma and COPD Devices Market report.

Presence of low quality products and rise in price competition are challenging the growth of the market.

Request for Sample of the Report @

Asthma and COPD Devices Market Segment Analysis - By Geography

North America dominated the Asthma and COPD Devices market share accounting for 38% of the market in 2019. This is mainly owing to increasing geriatric population in this region coupled with increasing prevalence of both diseases. According to the Centers for Disease Control and Prevention (CDC), in United States around 19.2 million (7.7%) adults aged 18 and over had asthma in 2018.

Asthma and COPD Devices Market Drivers

Increasing prevalence of Respiratory Disorders

According to World Health Organization (WHO), globally around more than 339 million people are living with asthma. Increasing prevalence of asthma and COPD Chronic Obstructive Pulmonary Disease globally are some factors driving the growth of Asthma and COPD Devices market. Moreover, rising expenditure on healthcare is also set to increase the market growth.

Asthma And COPD Devices top 10 companies are Philips Healthcare, Merck & Company, Novartis AG, Smith’s Group Plc., PARI Pharma, GF Health Products, Boehringer Ingelheim GmbH, AstraZeneca Plc, Omron Healthcare, and 3M Company.

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to to discuss more about our consulting services.

FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2021 Proserve Technology, Inc.